MAY-20-13 Dr. Ronald Valdiserri writes to recognize the second anniversary of Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis and to share an important announcement from Dr. Howard Koh about plans to update and renew the existing plan through 2014-2016.
MAY-16-13 Dr. Howard Koh, the Assistant Secretary for Health, announced on May 16 that the partner agencies are committed and dedicated to renewing the Action Plan for another three years and are currently working on their vision and priorities for 2014-2016.
|Advancing HCV Drug Development: A Collaborative Approach|
DEC-06-10 A public meeting on HCV drug development was held Monday, December 6, 2010, in Washington, DC.
The Forum held this meeting to obtain public comments regarding future trial designs and endpoints, including evaluation of interferon and/or ribavirin sparing regimens and the use of two or more DAAs in treatment-naïve and treatment-experienced trials and in special populations. Additional issues encountered during the drug development process were also discussed.
The Forum brought together stakeholders from industry, patient advocates, academia, and regulators to discuss issues in clinical development of DAAs.
The Steering Committee for this project includes: